Market Research report for the upcoming technologies | Emergen Research (2025)

Robotic Surgery Consumables Market Size

The Robotic Surgery Consumables market is expected to grow from an estimated USD 5.2 billion in 2024 to USD 15.9 billion in 2033, at a CAGR of 13.2%.

The global Robotic Surgery Consumables market size is expected to grow from USD 5.2 billion by the end of 2024 to USD 15.9 billion by 2033, registering a revenue CAGR of 13.2% during the forecast period.

The market growth is driven by advancements in virtual and augmented realities as well as growth in surgical robotics technologies. Globally, more than 1.5 million robotic-assisted surgeries are done annually. Robotic surgeries constitute around 15-20 % of all the minimally invasive procedures that are undertaken worldwide, and this percentage is constantly rising each year.

The leading healthcare providers are heavily investing in research and development and have developed many innovative product offerings and increased the use of robotic platforms. This development has greatly enhanced surgical precision to allow a wide range of procedures that can be conducted with better accuracy and efficiency.

For instance, surgical robotic systems have been proven to reduce the surgery error rate by around 40%, thus improving the patient’s safety and clinical outcomes. The recovery time in patients has also been minimized; the stays in hospitals are around an average of 20-30%, and postoperative complications are minimal with such procedures.

Improved operating room management also occurs due to the growing use of robotic systems, as healthcare providers are able to treat more effectively. For instance, the adoption of robotic platforms in hospitals has increased surgical throughput by around 25%.

This demonstrates how technology assists in the ever-increasing demand for healthcare services. Technological advancements, improved patient outcomes, and operational efficiencies are the key factors driving the growth of the robotic surgery consumables market. Cost-effective robotic surgery platforms unlock tremendous opportunities in emerging markets as they increase access to advanced surgical procedures.

Increased affordability drives the demand for the growing use of consumables, whereas increased competition will automatically drive more innovation in the process of manufacturing and cost-cutting; hence, the product becomes available to a much wider customer base. Such factors continue to drive the adoption of robotic surgical systems and the growth of the robotic surgery consumables market.

Robotic Surgery Consumables Market Drivers

Rise in the Adoption of Robotic Surgeries Driven by the Growing Geriatric Population

The growing population of geriatric patients across the globe results in increasing chronic diseases and the requirement for frequent surgical interventions, which is driving the adoption of robotic surgeries.

Cardiovascular diseases, orthopaedic disorders, and cancers are more common among older adults, thus demanding minimally invasive procedures that reduce the recovery time and minimize surgical risks.

In 2022, as per the United Nations' World Population Aging Report, around 10% of people worldwide belonged to the age category of 65 years and more, which is expected to grow exponentially over the forthcoming years.

The high precision and low invasiveness of robotic surgeries make them suitable for high-age patients or those who suffer from comorbidities or a compromised capacity to heal. For instance, Intuitive Surgical's da Vinci robotic system has been widely adopted for urologic and gynecologic surgeries, which are commonly required by older demographics.

In 2023, the company reported over 7,500 installations globally, with a significant share of procedures being performed on elderly patients. Furthermore, Medtronic’s Hugo RAS system, launched in 2022, has gained significant traction in addressing this demographic’s surgical needs, particularly in Asia-Pacific and Europe.

The rise in robotic surgeries reflects a healthcare system increasingly geared towards accommodating the growing geriatric population with advanced patient-centric technologies, ensuring better clinical outcomes and shorter hospital stays. These factors are expected to increase the demand for the robotic surgery consumables market.

Robotic Surgery Consumables Market Restraints

The high cost of surgical robotic systems and associated procedures are Expected to Hamper Market Growth

The major drawback of surgical robotic systems and procedures is their high cost. These systems require a significant upfront investment, often in excess of $2 million per unit, making them financially out of reach for many healthcare institutions, in resource-poor regions.

Apart from the initial investment, the costs of consumables and surgical instruments add to the expenses over time. For instance, the da Vinci Xi 12 mm reusable Hasson Cone retails at a price of $995 per piece, which is way above other surgical instruments.

Other costs of maintenance contracts, software upgrades, and staff training only add more weight to this economic burden; hence, this technology is strictly adopted in wealthy healthcare facilities and affluent regions only, which limits its adoption, thus hampering the market growth of the robotic consumables market.

Such high-cost variance also affects access in patients; robot-assisted surgeries are expensive to conduct; thus, fees of the process itself are high and much greater due to these overhead costs for running the unit, which hospitals face.

In many low-income countries with limited healthcare funding, the high costs of robotic systems remain an unattainable luxury for most, accessible only to a few well-insured individuals or those able to afford the expense out-of-pocket.

To address this inequality, it is crucial to focus on developing affordable robotic systems, adopting innovative pricing strategies, and introducing financial assistance programs to make these transformative technologies accessible to a wider population.

Robotic Surgery Consumables Market Segment Insights

Robotic Surgery Consumables Product Type Insights

The product type segment comprises end effectors, closures, access and facilitation equipment, and other consumables. End effectors are an integral part of the intellectual property portfolio of a company.

The top market players typically manufacture their end effectors to ensure perfect compatibility with their proprietary robotic surgery systems. Third-party vendors' counterfeit instruments pose great risks, such as patient deaths and increased procedural hazards.

Manufacturers overcome such problems by including pre-programmed IDs in their instruments so that the interface of the robotic system recognizes them once attached. Counterfeit products, lacking this recognition capability, become non-functional and worthless.

The increasing demand for smaller and more precise end effectors in complex surgical procedures is expected to fuel market growth. Manufacturers are witnessing significant investment in research and development in the end-effector in aspects of design, materials, and biocompatibility.

Competitive rivalry remains heavily dominated by leading players, primarily Intuitive Surgical, Inc., which tops the list by a notch to continually set quality and innovation benchmarks in the market.

Robotic Surgery Consumables Regional Insights

Robotic Surgery Consumables North America Market

North America held the largest market share of the global Robotic Surgery Consumables market in 2024. The growth in the market is fueled by high numbers of patients adopting advanced surgical technologies along with a robust and expanding healthcare industry. North America is expected to be the key revenue-generating country within this region, and then comes the United States.

For instance, in November 2024, Johnson & Johnson MedTech, one of the leading companies in providing cardiovascular, orthopaedic, surgical, and vision care solutions globally, reported that the US Food & Drug Administration, or FDA, has given IDE approval to its OTTAVA robotic surgical system.

This will propel the market growth across North America. Rising cases of chronic diseases, together with a growing demand for more sophisticated surgical procedures, will drive robotic surgery consumables growth in the APAC region.

Supportive government initiatives, favourable reimbursement policies, and collaboration between healthcare service providers and technology companies are further driving the growth of the market in the region.

Robotic Surgery Consumables Asia Pacific Market

The Asia Pacific region is the fastest-growing market for robotic surgery consumables, as growing healthcare demand caused by chronic diseases and an ageing population are expected in this region. Advanced surgical technologies, including robotics, are being increasingly adopted due to their precision and efficiency.

Investments from the government and good reimbursement policies are driving the market growth. Favourable collaborations with healthcare provider organizations and with technology companies continue to drive this market growth.

Microsurgery, a robotic surgery currently in development (as of the May 2024 announcement) by Sony Group Corporation, has designed a robot to perform automatic instrument exchange and will be able to improve precision.

These developments propel the growth in the Asia-Pacific region. It's further adding steam to its growth through its expansion in cost-effective robotic solutions in the medical tourism sector growth. Therefore, the regional area of APAC is to experience more leads through market expansions among healthcare professionals training in this process.

Robotic Surgery Consumables Top Companies and Competitive Landscape

Market competition in the Robotic Surgery Consumables industry is characterized by the presence of global and regional players such as Stryker Corporation (Mako Surgical Corporation), Virtual Incision Corporation, THINK Surgical, Inc., CMR Surgical Ltd., Meerecompany, Inc., Zimmer Biomet Holdings (Medtech SA), Renishaw plc, Johnson & Johnson (Auris Health, Inc.), Intuitive Surgical, Inc., Medtronic plc.

(Mazor Robotics), Venus Concept (Restoration Robotics, Inc.), Smith & Nephew plc., Stereotaxis, Inc., Asensus Surgical US, Inc. (Transenterix, Inc.) and others. The global Robotic Surgery Consumables market is highly scattered, with the considerable competition.

The leading players in the market are continuously adopting various growth strategies to maintain their established positions. The strategies include the launch of new products, innovations, mergers and acquisitions, collaborations, and partnerships, as well as a significant focus on research and development.

The major players are also dedicating huge efforts to research and development to provide the industry with the most efficient and cost-effective solutions.

In August 2023, Stryker initiated a direct-to-patient marketing program to improve patient engagement and education. The campaign is targeted directly at patients and provides them with information regarding Stryker's innovative medical solutions, focusing particularly on joint replacement procedures.

Some of the key companies in the global Robotic Surgery Consumables Market include:

• Johnson & Johnson (Auris Health, Inc.)
• Intuitive Surgical, Inc.
• Medtronic plc. (Mazor Robotics)
• Zimmer Biomet Holdings (Medtech SA)
• Renishaw plc.
• Venus Concept (Restoration Robotics, Inc.)
• Smith & Nephew plc.
• Stereotaxis, Inc.
• Stryker Corporation (Mako Surgical Corporation)
• THINK Surgical, Inc.
• CMR Surgical Ltd.
• Meerecompany, Inc.
• Virtual Incision Corporation
• Asensus Surgical US, Inc. (Transenterix, Inc.).

Robotic Surgery Consumables Latest Industry Updates

• In January 2022, Smith & Nephew furthered its dominance of the knee arthroscopy market through the purchase of Engage Surgical. This organization primarily specializes in making cementless knee systems in the United States. This strategic development further enhances Smith & Nephew's capacities regarding meniscal tear solutions and builds the portfolio of innovative orthopaedic devices for a wider space in the field of knee surgery.
• In January 2021, DePuy Synthes, a company of the Johnson & Johnson Medical Devices Companies, announced the FDA approval of its VELYS robotic system. It was an important step ahead for the orthopaedic portfolio of the company and added value significantly to the ATTUNE TOTAL knee system.

Robotic Surgery Consumables Report Summary

Robotic Surgery Consumables Market Segmentation Analysis

By Product Type

Outlook (Revenue, USD Million; 2020-2033)

• Access and Facilitation Equipment
• End Effectors
• Closure
• Other Consumables

By

Application Outlook (Revenue, USD Million; 2020-2033)

• General Surgery
• Gynecology Surgical Procedure
• Urology Surgical Procedure
• Orthopedic Surgical Procedure
• Cardiology Surgical Procedure
• Head and Neck Surgical Procedure
• Other Surgical Procedure

By End User Outlook (Revenue, USD Million; 2020-2033)

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Others

By

Regional Outlook (Revenue, USD Million; 2020-2033)

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Rest of Europe
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Turkey
  • Rest of MEA

Key Questions the Report Will Answer

• What was the market size of the Robotic Surgery Consumables market in 2024?

  • The Robotic Surgery Consumables market size in 2024 was USD 5.2 Billion.

• What is the expected revenue Compound Annual Growth Rate (CAGR) of the Robotic Surgery Consumables market over the forecast period?

  • The Robotic Surgery Consumables market is expected to register a revenue Compound Annual Growth Rate (CAGR) of 13.2% over the forecast period.

• Which factors are expected to drive Robotic Surgery Consumables market revenue growth?

  • Rise in the Adoption of Robotic Surgeries Driven by the Growing Geriatric Population are expected to drive revenue growth of the global Robotic Surgery Consumables market.

• Which regional market is expected to account for the largest revenue share in the Robotic Surgery Consumables market?

  • The North America market is expected to account for the largest revenue share in the Robotic Surgery Consumables market over the forecast period.

• Which are some of the major companies included in the global Robotic Surgery Consumables market report?

• Some of the major companies in the global Robotic Surgery Consumables market include Johnson & Johnson (Auris Health, Inc.), Intuitive Surgical, Inc., Medtronic plc (Mazor Robotics), Zimmer Biomet Holdings (Medtech SA), Renishaw plc, Venus Concept (Restoration Robotics, Inc.), Smith & Nephew plc, Stereotaxis, Inc., Stryker Corporation (Mako Surgical Corporation), THINK Surgical, Inc., CMR Surgical Ltd., Meerecompany, Inc., Virtual Incision Corporation, and Asensus Surgical US, Inc. (TransEnterix, Inc.).